Introduction to HEK293 and HeLa Cells
HEK293 and HeLa cells have fundamentally transformed the landscape of drug development, serving as essential tools for researchers globally. These cell lines have significantly advanced our understanding of human biology and facilitated the discovery and testing of a multitude of therapeutic compounds.

The Origin of HEK293 Cells
HEK293 cells, or Human Embryonic Kidney 293 cells, were derived from a human embryonic kidney cell line in 1973. Transformed with adenovirus DNA, they became immortalized, exhibiting unique properties that make them ideal for various research applications, particularly in drug development.

The History of HeLa Cells
In contrast, HeLa cells have a more complex and controversial history. Derived from a cervical cancer sample taken from Henrietta Lacks, an African-American woman, in 1951, these cells were cultured and distributed to researchers without her knowledge or consent, leading to significant advancements in biomedical research but also raising ethical concerns.

Read more: https://picuki.ca/hek293-and-hela-cells-pioneering-tools-in-drug-development/